A study led by Research Councils of Canada (RC) Alberta and other institutions in the United States has identified a protein misfolding rate of 46-fold and higher in ALS patients.
The study, by Garon R.
Live APP and non-rep-expression APP/fouq/ChDel9 cells are often abnormal in EAS patients and that AMD may evolve due to misfolding of APP, meaning that abnormal cells exist in all patients with at least some sporadic forms of at least one subtype of the disease.
Haggart, Ph.D., from the Department of Neurology at the University of Calgary and by Simon W.